Evaluation of current strategies and future priorities for improving health in developing countries.
about
Cost effectiveness analysis of strategies for tuberculosis control in developing countries.A literature review of economic evaluations for a neglected tropical disease: human African trypanosomiasis ("sleeping sickness")Using Economic Evidence to Set Healthcare Priorities in Low-Income and Lower-Middle-Income Countries: A Systematic Review of Methodological Frameworks.Countdown to 2015: will the Millennium Development Goal for child survival be met?Priority setting in developing countries health care institutions: the case of a Ugandan hospital.Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules.Multi-criteria decision analysis of breast cancer control in low- and middle- income countries: development of a rating tool for policy makersCost effectiveness analysis of strategies for maternal and neonatal health in developing countries.Systematic reviews need to consider applicability to disadvantaged populations: inter-rater agreement for a health equity plausibility algorithm.Priority setting of health interventions: the need for multi-criteria decision analysis.The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model.A cost-effectiveness analysis of a program to control rheumatic fever and rheumatic heart disease in Pinar del Rio, CubaReimbursement policies in the Asia-Pacific for chronic hepatitis B.An economic perspective on Malawi's medical "brain drain".Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis.Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study.Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study.Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.Capacity utilization and the cost of primary care visits: implications for the costs of scaling up health interventions.Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysisImpact of a community sexually transmitted infection/HIV intervention project on female sex workers in five border provinces of Vietnam.The costs of a sexually transmitted infection outreach and treatment programme targeting most at risk youth in TajikistanRanking 93 health interventions for low- and middle-income countries by cost-effectivenessCost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children ≤60 months of age.Cost-effectiveness of heat and moisture exchangers compared to usual care for pulmonary rehabilitation after total laryngectomy in Poland.Marigold dream, maternal nightmare.Costs, effects and cost-effectiveness of breast cancer control in Ghana.Distributional cost-effectiveness analysis in low-and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia.An implicit price of a DALY for use in a cost-benefit analysis of ARVs
P2860
Q24538952-0517184A-5E44-4873-ADCE-E3DCB2E289F3Q26826895-B4216E4D-CDCA-4638-BB3D-8CCE10FBCCAFQ28074172-FD35D6C7-C66B-4CFB-9401-10A2AB1125C6Q30396921-48A5FE3C-D3CA-449C-A9BD-C634809CF42AQ33259660-71C19A10-30EA-4B21-B96F-F53A9885FAF9Q33606843-0886942C-6DB1-4E62-BC63-233277D327D2Q33650437-A7542459-C935-40A9-AFAC-FC07F2E7C761Q34131939-62191848-A2D4-445C-97ED-C9EC83BA50E8Q34518266-C5C63BBD-E12D-4EDE-9545-99AB93D84DACQ35017485-419663D4-DB98-4EC9-81D2-A8A2006C4995Q35169355-EF926E00-1D5C-432B-89B8-A095A121AFA2Q35175210-900243E7-EF4B-46A0-BDCF-BD770FB018F1Q35580986-654A9F97-A30A-422B-947D-978077ED1CCFQ35585402-8C643599-4760-4C50-B130-374F5FE776C0Q35798038-B10306EF-7C06-45FD-A60B-0964A3B14F8BQ35798048-FEEF7E16-F85D-40B7-A250-63DE7B480144Q35798061-62E430CD-63B2-4C2C-B2CD-6E22EB83664BQ35798096-209E2B86-A910-4D07-84FD-E2BFBF974B6FQ37067015-69000B6E-F1C0-4D7B-8E01-C43EB764261DQ37108920-084944FD-E0A6-488E-BCC1-39CFE2F957A7Q37136340-E60C6EA3-3468-4D9A-8C0D-88C2E1566466Q37428151-8A2C7B91-D757-4BE3-8D49-C75AFF888ACAQ39077555-B2880284-517F-433D-90D3-B0EDDEA5BF50Q40072175-909AD5F1-55D1-4BE6-9ECD-CC69B43BD780Q41126676-DCCD3DF1-EE7D-493F-97E9-6D2481AD12A5Q46809861-0EF4E3BF-7398-4895-8DFB-4AA0EF84071BQ47371218-C04FC5C7-CF3C-4A37-A389-A9F565E1BEFEQ47564040-62C4409B-3708-4D34-8781-D125C89810EFQ58304513-7FA83803-86D0-45B8-9299-449A24CFF95C
P2860
Evaluation of current strategies and future priorities for improving health in developing countries.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Evaluation of current strategi ...... ealth in developing countries.
@ast
Evaluation of current strategi ...... ealth in developing countries.
@en
Evaluation of current strategi ...... ealth in developing countries.
@nl
type
label
Evaluation of current strategi ...... ealth in developing countries.
@ast
Evaluation of current strategi ...... ealth in developing countries.
@en
Evaluation of current strategi ...... ealth in developing countries.
@nl
prefLabel
Evaluation of current strategi ...... ealth in developing countries.
@ast
Evaluation of current strategi ...... ealth in developing countries.
@en
Evaluation of current strategi ...... ealth in developing countries.
@nl
P2093
P2860
P1433
P1476
Evaluation of current strategi ...... ealth in developing countries.
@en
P2093
David B Evans
Stephen S Lim
Taghreed Adam
Tessa Tan-Torres Edejer
WHO Choosing Interventions tha ...... lennium Development Goals Team
P2860
P304
P356
10.1136/BMJ.38658.675243.94
P407
P577
2005-11-10T00:00:00Z